药品优化创新中心:一个专门的中心,推动药品优化创新,影响力和可持续性
1Medicines Optimisation Innovation Centre, Antrim, Northern Ireland. Anita.hogg@northerntrust.hscni.net.
International journal of clinical pharmacy
|July 23, 2024
概括
药品优化创新中心 (MOIC) 通过告知政策和支持卫生系统,成功改善了全球药品使用情况. 它的可持续模式提供了一种可复制的方法,通过优化药物管理来提高人口健康和福祉.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 制药政策 制药政策
- 公共卫生创新 公共卫生创新
背景情况:
- 低于最佳的药物使用是一个全球性挑战,对健康结果,效率和资源利用产生负面影响.
- 药品优化创新中心 (MOIC) 于2015年在北爱尔兰成立,通过支持药品优化质量框架来解决这些问题.
研究的目的:
- 为了说明药品优化创新中心 (MOIC) 如何影响卫生政策.
- 展示MOIC在支持专员提高人口健康和福祉方面的作用.
主要方法:
- MOIC作为一个区域中心运作,拥有卫生和社会护理领域的多学科专业知识,包括患者代表.
- 卫生部的核心资金为MOIC提供了强有力的治理,年度业务计划和严格的项目采用流程.
- MOIC促进与学术界,工业界,医疗保健组织和欧洲合作伙伴的合作,参与研发和测试综合技术解决方案.
主要成果:
- MOIC已经获得了许多协议,参与了三个主要的欧盟项目,并通过出版物和演讲扩大了其全球网络.
- 该中心影响了路径重新设计,可持续性倡议和COVID-19应对措施,同时帮助欧洲和非洲发展临床药房和抗菌药物管理.
- 北爱尔兰被认定为欧洲活跃和健康老龄化参考站点,其综合药物管理模式被列为中东欧最佳实践.
结论:
- 药品优化创新中心 (MOIC) 取得了重大成功,并证明了可持续性.
- MOIC的模型具有适应性,适用于世界各地的各种健康系统,为改善药物管理和健康结果提供可扩展的解决方案.
相关概念视频
01:29Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
01:26Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
149
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
149
01:28Structure-Activity Relationships and Drug Design
694
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
694
01:19Pharmacovigilance
810
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
810
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K